Hutchinson-Gilford progeria syndrome, cardiovascular disease and oxidative stress

Laia Trigueros-Motos1, Jose M Gonzalez, Jose Rivera

  • 1Department of Epidemiology, Atherothrombosis and Cardiovascular Imaging, Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.

Insights

Hutchinson-Gilford Progeria Syndrome (HGPS) involves progerin accumulation, causing premature aging and cardiovascular issues. Research explores HGPS mechanisms, oxidative stress, and potential treatments for this rare disease.

Area of Science:

  • Gerontology
  • Molecular Biology
  • Cardiovascular Medicine

Background:

  • Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare genetic disorder characterized by accelerated aging.
  • The disease is primarily caused by the accumulation of progerin, a toxic protein derived from lamin A.
  • HGPS patients frequently suffer from severe vascular alterations, leading to early mortality from heart attack or stroke.

Purpose of the Study:

  • To review recent advancements in understanding the molecular mechanisms of cardiovascular alterations in HGPS.
  • To explore the potential role of oxidative stress in HGPS pathogenesis.
  • To discuss current and emerging therapeutic strategies for HGPS.

Main Methods:

  • Review of existing literature on HGPS molecular mechanisms.
  • Analysis of studies on progerin accumulation and its cellular effects.
  • Examination of research on oxidative stress in aging and HGPS.
  • Synthesis of data on therapeutic interventions for HGPS.

Main Results:

  • Progerin accumulation is central to HGPS pathology, affecting nuclear envelope stability and cellular function.
  • Vascular damage, including atherosclerosis and stiffening, is a hallmark of HGPS.
  • Evidence suggests a complex interplay between HGPS, normal aging processes, and oxidative stress.

Conclusions:

  • Understanding HGPS molecular pathways offers insights into normal aging.
  • Targeting progerin accumulation and oxidative stress are key therapeutic avenues.
  • Further research is crucial for developing effective treatments for HGPS and related aging conditions.

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...